Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +47.15%
#3 Pons Pons +44.66%
#4 Non-Playable Coin Non-Playable Coin +28.34%
#5 StonkBroker StonkBroker +24.99%
#6 Kinetiq Kinetiq +24.50%
#7 ApeX ApeX +24.20%
#8 OriginTrail OriginTrail +19.97%
#9 Pudgy Penguins Pudgy Penguins +19.48%
#10 Grass Grass +19.15%
Coin of the day
Smilek to the Bank Smilek to the Bank
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

SPPI
Classement en actions #21095
Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily... Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily engaged in the research, development, and market introduction of innovative drug products for cancer and blood disorders. Its robust pipeline features Eflapegrastim, an advanced, long-acting granulocyte colony-stimulating factor designed to address chemotherapy-induced neutropenia. Also under development is Poziotinib, a distinct irreversible tyrosine kinase inhibitor intended for non-small cell lung cancer tumors exhibiting various mutations. Furthermore, Anti-CD20-IFNa, an antibody-interferon fusion molecule targeting CD20, is progressing through Phase I development for patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. The company maintains key collaborative agreements, such as co-development, commercialization, and in-licensing arrangements with Hanmi Pharmaceutical Co. Ltd., a patent and technology license with The University of Texas M.D. Anderson Cancer Center, and an in-license pact with ImmunGene, Inc. Founded in 1987, and initially known as NeoTherapeutics, Inc. before its name change in December 2002, Spectrum Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
Prix de l'action
$1.03
Dernière synchronisation: 2023-07-31
Capitalisation boursière
$115.13M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Spectrum Pharmaceuticals, Inc. (SPPI)

Catégorie

Healthcare
Le prix SPPI avec la capitalisation boursière de B
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.
SPPI
$1.03
Capitalisation boursière de Spectrum Pharmaceuticals, Inc.(SPPI)
Capitalisation boursière: $115.13M
En August 2026, Spectrum Pharmaceuticals, Inc. a une capitalisation boursière de $115.13M. Cela fait de Spectrum Pharmaceuticals, Inc. la 21095th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Spectrum Pharmaceuticals, Inc. du 1996 au 2026
SPPI par rapport au top 5 des plus populaires stocks
Prix pour SPPI L’actif B La capitalisation boursière de B Résultats
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.
$46,621.61 $115.13M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,526,270.13%
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.
$40,675.81 $115.13M
Apple Inc. Apple Inc.
AAPL
$4.547T +3,949,007.36%
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.
$37,238.07 $115.13M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,615,247.00%
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.
$32,141.59 $115.13M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,120,442.98%
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.
$24,985.25 $115.13M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,425,652.74%